日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Daucus carota Sucrose synthase isoform 2, partial CSB-YP525077DIR
CSB-EP525077DIR
CSB-BP525077DIR
CSB-MP525077DIR
CSB-EP525077DIR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Glycine max Ferredoxin-thioredoxin reductase catalytic chain, chloroplastic (FTRC) CSB-YP525078GGV
CSB-EP525078GGV
CSB-BP525078GGV
CSB-MP525078GGV
CSB-EP525078GGV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Populus tremuloides Phytochrome A (PHYA), partial CSB-YP525080EXR
CSB-EP525080EXR
CSB-BP525080EXR
CSB-MP525080EXR
CSB-EP525080EXR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Brassica juncea S-adenosylmethionine decarboxylase proenzyme 2 (SAMDC2) CSB-YP525081BWC
CSB-EP525081BWC
CSB-BP525081BWC
CSB-MP525081BWC
CSB-EP525081BWC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Ornithine carbamoyltransferase, chloroplastic (OTC) CSB-YP525082DOA
CSB-EP525082DOA
CSB-BP525082DOA
CSB-MP525082DOA
CSB-EP525082DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus horikoshii Probable deoxyhypusine synthase (dys) CSB-YP525083FHX
CSB-EP525083FHX
CSB-BP525083FHX
CSB-MP525083FHX
CSB-EP525083FHX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ruminococcus albus ATP synthase epsilon chain (atpC) CSB-YP525084ROS
CSB-EP525084ROS
CSB-BP525084ROS
CSB-MP525084ROS
CSB-EP525084ROS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Borrelia burgdorferi S-ribosylhomocysteine lyase (luxS) CSB-YP525085BUD
CSB-EP525085BUD
CSB-BP525085BUD
CSB-MP525085BUD
CSB-EP525085BUD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycoplasma hyopneumoniae Ribosomal RNA small subunit methyltransferase E (rsmE) CSB-YP525086MWK
CSB-EP525086MWK
CSB-BP525086MWK
CSB-MP525086MWK
CSB-EP525086MWK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Zymomonas mobilis Carbamoyl-phosphate synthase large chain (carB), partial CSB-YP525087ZBM
CSB-EP525087ZBM
CSB-BP525087ZBM
CSB-MP525087ZBM
CSB-EP525087ZBM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus halodurans 10 kDa chaperonin (groS) CSB-YP525088BQS
CSB-EP525088BQS
CSB-BP525088BQS
CSB-MP525088BQS
CSB-EP525088BQS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlorobaculum parvum Magnesium-chelatase 67 kDa subunit (bchD), partial CSB-YP525089DSQ
CSB-EP525089DSQ
CSB-BP525089DSQ
CSB-MP525089DSQ
CSB-EP525089DSQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Probable ribonuclease VapC46 (vapC46) CSB-YP525090MVZ
CSB-EP525090MVZ
CSB-BP525090MVZ
CSB-MP525090MVZ
CSB-EP525090MVZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Antitoxin RelB (relB) CSB-YP525091MVZ
CSB-EP525091MVZ
CSB-BP525091MVZ
CSB-MP525091MVZ
CSB-EP525091MVZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant 30S ribosomal protein S7 (rpsG) CSB-YP525092TNZ
CSB-EP525092TNZ
CSB-BP525092TNZ
CSB-MP525092TNZ
CSB-EP525092TNZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus halodurans Translation initiation factor IF-1 (infA) CSB-YP525093BQS
CSB-EP525093BQS
CSB-BP525093BQS
CSB-MP525093BQS
CSB-EP525093BQS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus halodurans 50S ribosomal protein L17 (rplQ) CSB-YP525094BQS
CSB-EP525094BQS
CSB-BP525094BQS
CSB-MP525094BQS
CSB-EP525094BQS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Borrelia burgdorferi Uncharacterized lipoprotein BBF20 (BB_F20) CSB-YP525095BUD
CSB-EP525095BUD
CSB-BP525095BUD
CSB-MP525095BUD
CSB-EP525095BUD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Borrelia burgdorferi UPF0118 membrane protein BB_0006 (BB_0006), partial CSB-YP525096BUD
CSB-EP525096BUD
CSB-BP525096BUD
CSB-MP525096BUD
CSB-EP525096BUD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Borrelia burgdorferi S-adenosylmethionine:tRNA ribosyltransferase-isomerase (queA) CSB-YP525097BUD
CSB-EP525097BUD
CSB-BP525097BUD
CSB-MP525097BUD
CSB-EP525097BUD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×